SOURCE: Metiscan, Inc

Metiscan, Inc

December 16, 2011 09:30 ET

Metiscan's Subsidiary Aclor Announces Partnership to Produce 14 Million Notebooks to 125 Universities Nationwide

DALLAS, TX--(Marketwire - Dec 16, 2011) - Metiscan, Inc. (PINKSHEETS: MTIZ) announces today that 2012 marks the first of a five-year partnership between Aclor and Diretec, whereby Aclor through Aclor Servicios Operativos will produce 14 million ABS notebooks for a network of 125 universities nationwide including Harvard, MIT, Cornell, U Penn, Texas A&M and Southern California. Aclor's factory in Nuevo Laredo will produce the ABS notebooks under the Principa brand.

"We are excited to begin this partnership in 2012," commented Peter Yang, the Chief Operating Officer of Metiscan, Inc., who contributed significantly to establishing the partnership between Aclor and Diretec. "We look forward to this partnership and the $14M in new revenues it may create for us over the next five years."

Diretec is a provider of idea-based notebooks to university youths. Diretec has a network of over 500 universities worldwide. Diretec's Principa brand has offices located in New York, Houston, Los Angeles and Miami. For more information visit

Metiscan, Inc. is a public holding company traded on the Pink Sheets under the symbol MTIZ. Its sole, wholly-owned subsidiary Aclor, Inc. is an international manufacturer and supplier of private label paper products. Aclor's customers include some of the most recognized and reputable office supply mass retailers worldwide and also include the largest consumer and office retailer in the United States. Aclor produces composition notebooks, spiral notebooks, wireless notebooks, and filler paper in its factory located in Nuevo Laredo, Tamaulipas, Mexico.

Safe Harbor Statement: Certain of the statements made in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause Metiscan's actual results to be materially different from the historical results or from any future results expressed or implied by such forward-looking statements. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes," "belief," "intends," "anticipates" or "plans" to be uncertain and forward-looking. The Company does not intend to update any of the forward-looking statements after the date of this release to conform these statements to actual results or to changes in its expectations, except as may be required by law.

Contact Information

  • Investor Relations Contact:
    Dylan Yarter
    Voice: +1 (214) 872-6570
    Email Contact